Michelle Monje
Founding Director · Stanford Health Care
Credentials: · · · ·
History
- Present
- Present
- 2009–2010
- 2005–2008
Brigham and Women's Hospital Harvard Medical School (2008) MA
2004–2005
- 1996–2000
Research
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
Cell · 2019 · 2,158 citations
Inflammatory blockade restores adult hippocampal neurogenesis
Science · 2003 · First of 3 authors · 1,959 citations
Microglia states and nomenclature: A field at its crossroads
Review · Neuron · 2022 · 1,602 citations
18 papers
17 papers
16 papers · 4 as a fellow
- CM
15 papers · 6 as a resident
14 papers
12 papers
11 papers
11 papers
Grants
- 2021–2027
Harvard/Stanford GTN Program: Novel Targeted Therapeutics for Glioblastoma
National Cancer Institute · U19
Project lead · $1.4M · Brigham and Women's Hospital
- 2022–2027
Neuronal Regulation of Low-Grade Gliomagenesis
National Cancer Institute · R01
Contact PI · $3.1M · Stanford University
- 2021–2026
Developing Safe and Effective GD2-CAR T Cell Therapy for Diffuse Midline Gliomas
National Cancer Institute · R01
PI · $3.3M · Stanford University
- 2018–2024
Glioma Circuitry: Bridging Systems Neuroscience and Cancer
National Institute of Neurological Disorders and Stroke · DP1
Contact PI · $5.7M · Stanford University
Clinical trials
- 2020–2043
GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)
Principal investigator · Recruiting · Phase 1
Stanford University
- 2016–2024
Trial of Panobinostat in Children With Diffuse Intrinsic Pontine Glioma
Principal investigator · Completed · Phase 1
Pediatric Brain Tumor Consortium
- 2020–2024
INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas
Study chair · Completed · Phase 1
Pediatric Brain Tumor Consortium